Dafna Capital Management LLC Xenon Pharmaceuticals Inc. Transaction History

Dafna Capital Management LLC

$389 Million
Q3 2024

A detailed history of Dafna Capital Management LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 273,739 shares of XENE stock, worth $10.6 Million. This represents 2.77% of its overall portfolio holdings.

Number of Shares

273,739

Previous 273,739 -0.0%

Holding current value

$10.6 Million

Previous $10.7 Million 0.92%

% of portfolio

2.77%

Previous 2.74%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $127,979 - $150,120	-3,000 Reduced 1.08%	273,739 $11.8 Million
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $109,031 - $176,501	-3,799 Reduced 1.35%	276,739 $12.7 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $1.24 Million - $1.55 Million	-35,554 Reduced 11.25%	280,538 $10.8 Million
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $1.95 Million - $2.33 Million	-59,131 Reduced 15.76%	316,092 $12.5 Million
Q3 2022 Nov 14, 2022	SELL	$30.79 - $39.82 $1.95 Million - $2.52 Million	-63,400 Reduced 14.45%	375,223 $13.5 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $1.49 Million - $2.06 Million	58,460 Added 15.38%	438,623 $13.3 Million
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $564,625 - $745,557	-22,504 Reduced 5.59%	380,163 $11.6 Million
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $60,340 - $136,927	-3,868 Reduced 0.95%	402,667 $12.6 Million
Q1 2021 May 17, 2021	BUY	$13.65 - $21.31 $819,000 - $1.28 Million	60,000 Added 17.31%	406,535 $7.28 Million
Q1 2020 May 15, 2020	BUY	$8.08 - $17.57 $789,262 - $1.72 Million	97,681 Added 39.25%	346,535 $3.93 Million
Q4 2019 Feb 14, 2020	SELL	$8.11 - $14.65 $663,503 - $1.2 Million	-81,813 Reduced 24.74%	248,854 $3.26 Million
Q1 2019 May 15, 2019	BUY	$6.39 - $10.42 $594,167 - $968,893	92,984 Added 39.12%	330,667 $3.36 Million
Q3 2018 Nov 14, 2018	SELL	$9.0 - $14.9 $510,111 - $844,517	-56,679 Reduced 19.25%	237,683 $3.14 Million
Q2 2018 Aug 13, 2018	SELL	$4.8 - $9.2 $399,998 - $766,663	-83,333 Reduced 22.06%	294,362 $2.71 Million
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.25 $925,352 - $1.23 Million	377,695	377,695 $1.11 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Xenon Pharmaceuticals Inc. Transaction History